Metabolic: week 48 comparison of metabolic parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavir
| dc.contributor.author | Overton, T. | |
| dc.contributor.author | Aberg, J. A. | |
| dc.contributor.author | Gupta, S. | |
| dc.contributor.author | Ryan, R. | |
| dc.contributor.author | Baugh, B. | |
| dc.contributor.author | De La Rosa, G. | |
| dc.contributor.department | Medicine, School of Medicine | |
| dc.date.accessioned | 2025-03-06T12:23:33Z | |
| dc.date.available | 2025-03-06T12:23:33Z | |
| dc.date.issued | 2010-11-08 | |
| dc.eprint.version | Final published version | |
| dc.identifier.citation | Overton T, Aberg JA, Gupta S, Ryan R, Baugh B, De La Rosa G. Metabolic: week 48 comparison of metabolic parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavir. J Int AIDS Soc. 2010;13(Suppl 4):P74. Published 2010 Nov 8. doi:10.1186/1758-2652-13-S4-P74 | |
| dc.identifier.uri | https://hdl.handle.net/1805/46240 | |
| dc.language.iso | en_US | |
| dc.publisher | Wiley | |
| dc.relation.isversionof | 10.1186/1758-2652-13-S4-P74 | |
| dc.relation.journal | Journal of the International AIDS Society | |
| dc.rights | Attribution 4.0 International | en |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.source | PMC | |
| dc.subject | Protease inhibitors | |
| dc.subject | Metabolic complications | |
| dc.subject | Cardiovascular risk | |
| dc.subject | HIV infection | |
| dc.subject | Darunavir/ritonavir (DRV/r) based therapy | |
| dc.subject | Atazanavir/ritonavir (ATV/r) based therapy | |
| dc.title | Metabolic: week 48 comparison of metabolic parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavir | |
| dc.type | Article |